Denmark is set to investigate whether the weight-loss drug Wegovy can help boost employment rates. The Nordic nation was an early adopter of Novo Nordisk’s medication, having introduced Wegovy to its market in late 2022. (Photographer: Hilary Swift/Bloomberg)
Source: Bloomberg Generated at: 2026-06-04 11:11:00 UTC
Morgan Stanley predicts Zambia’s Eurobond prices will rise, breaking the current valuation stalemate. This surge aims to...
Apollo’s Jim Zelter reports that high-grade corporate debt sales have recently surpassed US Treasury issuance volumes.
Nasdaq 100 futures declined as Broadcom’s disappointing forecast unsettled traders.
Blackstone’s BCRED fund is restricting investor redemptions to manage liquidity pressures. This move aligns it with othe...
Sugar futures rose for a third day as Brazilian mills shift to ethanol due to rain-damaged crops. This reduces sugar sup...
Declining US oil inventories signal a market warning, though nearing storage limits may alleviate fears. This shift impa...
